Results 261 to 270 of about 208,685 (341)

Heart matters: How glucose‐ and lipid‐modulating drugs remodel epicardial adipose tissue accumulation, inflammatory patterns and browning

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Epicardial adipose tissue (EAT) is a metabolically active visceral fat depot located between the myocardium and the visceral pericardium, exerting direct paracrine and vasocrine effects on the heart and coronary vessels. Under physiological conditions, EAT supports myocardial energy metabolism and thermoregulation through fatty acid supply and
Elisabeth Heuboeck, Charnkamal Singh Bhogal, Markus Mandl   +2 more
wiley   +1 more source

Prevalence and impact of abnormal blood pressure on left ventricular hypertrophy in adolescents with congenital heart disease. [PDF]

Am J Prev Cardiol
Walsh AT, Hor KN, Eisner M, Alvarado C, Kallash M, Spencer JD, Tran AH.   +6 more
europepmc   +1 more source

Cardiovascular biomarkers and preeclampsia: A narrative review

European Journal of Clinical Investigation, EarlyView.
Preeclampsia (PE) is a complex pregnancy disorder linked to cardiovascular disease (CVD) through shared risk factors and epidemiological associations. Cardiovascular biomarkers are valuable for predicting, diagnosing and assessing PE, as well as estimating future CVD risk. This review explores current cardiovascular biomarkers used in clinical practice
Johana Ullmo, Madalina Nicoleta Nan, Mónica Cruz‐Lemini, Carmen Garrido‐Gimenez, Judit Platero, Álvaro García‐Osuna, Pablo García‐Manau, Marcel Twickler, Elisa Llurba   +8 more
wiley   +1 more source

Echocardiography Combined With Radiomics and Deep Transfer Learning to Diagnose Hypertrophic Cardiomyopathy and Other Etiologies of Left Ventricular Hypertrophy: A Multicenter Study Comparing the Performance With Echocardiologists. [PDF]

Rev Cardiovasc Med
Wang J, Wang S, Yu T, Tao W, Shao H, Xia C, Liu B.   +6 more
europepmc   +1 more source

Long‐term effectiveness and safety outcomes in adults with Fabry disease treated with agalsidase alfa: 20 years of data from the Fabry Outcome Survey

European Journal of Clinical Investigation, EarlyView.
Long‐term treatment with agalsidase alfa in 1864 adults with Fabry disease in the Fabry Outcome Survey confirmed previously reported beneficial effects on renal function and cardiomyopathy. Over a median (min, max) of 6.0 (0, 21.6) years of treatment, annualized changes in eGFR remained relatively stable in females and declined slightly in males.
Derralynn A. Hughes, Guillem Pintos‐Morell, Christoph Kampmann, Christina Anagnostopoulou, Jaco Botha, Siddharth Jain, Kathleen Nicholls, Dau‐Ming Niu, Ricardo Reisin, Michael L. West, Jörn Schenk, Uma Ramaswami, Roberto Giugliani   +12 more
wiley   +1 more source

Sex Difference in the Association Between Regional Adipose Tissue and Left Ventricular Hypertrophy. [PDF]

J Clin Med
Cho IJ, Lee SE, Pyun WB.
europepmc   +1 more source

Hemodynamic and microcirculatory early adaptations following transcatheter aortic valve implantation (TAVI): A physiological pilot study

European Journal of Clinical Investigation, EarlyView.
This pilot physiological study, involving 20 patients with severe aortic stenosis, shows that transcatheter aortic valve implantation (TAVI) induces rapid changes in both macrocirculatory parameters, reflecting the release of chronic obstruction. We observed improved tissue perfusion by postoperative Day 1, independent of macrocirculatory parameters ...
Stanislas Abrard, Sarah Mauler, Ivo Neto Silva, Dyonisios Adamopoulos, Stéphane Bar, Andres Hagerman, Raoul Schorer, Bernardo Bollen Pinto, Georgios Rovas, Nikolaos Stergiopulos, Christoph Ellenberger, Stéphane Noble, Karim Bendjelid   +12 more
wiley   +1 more source

High-Intensity Interval Training Improves Cardiovascular Fitness and Induces Left-Ventricular Hypertrophy During Off-Season. [PDF]

J Funct Morphol Kinesiol
Venckunas T, Gumauskiene B, Muanjai P, Cadefau JA, Kamandulis S.   +4 more
europepmc   +1 more source

A study of left ventricular hypertrophy with body surface isopotential maps

, 1986
Kazuo Ihoriya
openalex   +2 more sources

IL‐6 in the spotlight: From cardiovascular pathophysiology to therapy

European Journal of Clinical Investigation, EarlyView.
Interleukin‐6 (IL‐6) links inflammation to cardiovascular and multi‐organ dysfunction. This review integrates mechanistic, translational, and clinical evidence supporting IL‐6 as both a biomarker and therapeutic target in the continuum of cardiovascular and cardio‐renal disease.
Alberto Preda, Amedeo Tirandi, Giulio Leo, Davide Di Vece, Gemma Vilahur, Aldo Bonaventura, Elena Osto, Stefano Ministrini, Simon Kraler, Petra Kleinbogard, Giovanni Camici, Federico Carbone, Fabrizio Montecucco, Luca Liberale   +13 more
wiley   +1 more source